Vaccine Delivery Devices Market

  • A vaccine is a biological preparation that provides active acquired immunity to a particular disease. The types of vaccines include toxoid vaccine, conjugate vaccine, attenuated vaccine and killed vaccine.
  • The vaccine is transferred to the human body through a different medium (subconscious, intramuscular and intradermal) using a syringe or needle.
  • Needle-free vaccine delivery is novel technology which can be effectively used in mass immunization programs thereby reducing the chances of needle sticks injuries and the infections related in using a needle. The other vaccine deliveries include disposable syringes, jet injectors, and transdermal transfer.
  • The global vaccine delivery devices market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.

 

Vaccine Delivery Devices Market Drivers and Restraints

  • Increase in prevalence of the infectious diseases across the globe and demand for needle-free injections since it has the potential to decrease the dose of vaccine antigen and also enhances the immunogenicity.
  • Current technological advancement in terms of microneedles and transdermal patches for vaccine delivery are amplifying the growth.
  • The government initiatives from India and China regarding immunization programs are driving the global vaccine delivery devices market. According to the recent study conducted by researchers at National Journal Of Molecular Sciences, the oral polio vaccine has been established as a successful model of needle-free immunization.
  • According to the Centre Of Disease Control And Prevention in 2018, 34,100 cases of infectious diseases were imported to mainland China during 2005-2016.
  • Major factors hindering the global vaccine delivery devices market is the significant cost associated with the microneedles in the developed countries.

 

Vaccine Delivery Devices Market Segmentation Analysis

  • Global vaccine delivery devices market is segmented by product type, by route of administration, by end users and by region. Product type includes syringes, jet injectors, microneedles, and others, by direction of administration includes intradermal, subcutaneous vaccination and intramuscular vaccination and by the end, users include hospital pharmacies, retail pharmacies, online pharmacies, and vaccination centers.
  • Needle-free delivery is dominating the global vaccine delivery devices market in the route of administration segment due to increasing in adoption of needle-free devices during vaccination to avoid pain and injuries (needle sticks) associated during needle injections, increase in treatments through improperly sterilized syringes and needles in middle and low-income countries.
  • According to a recent study conducted by IPEN study Group found out that 3 billion injections were estimated and administrated annually in India out of which 1.89 billion were unsafe.
  • According to the study conducted by the center of disease control and prevention in 2018, more than 600,000 to one million needlestick injuries occurring each year in the world and half of them are unreported.

 

Vaccine Delivery Devices Market Geographical Share

  • The global vaccine delivery devices market is segmented into North America, Europe, Asia Pacific, South America, and ROW.
  • North America dominates the global vaccine delivery devices market due to extensive usage of vaccines for immunizations, increased health conscious in public, government and non-government funding in R&D of new vaccine technologies and also expected to remain high during the forecast period.
  • In March 2018, Colorado-based Pharma jet received about 5million fund to produce 5 million syringes to deliver polio vaccine.

 

Vaccine Delivery Devices Market Competitive Trends

  • Mergers between the key players and research organizations in R&D of needle-free and innovative vaccine delivery devices are driving the global vaccine delivery devices market.
  • In March 2017, PharmaJet, the maker of innovative, needle-free injection technology, merged with Serum Institute of India, the world’s largest vaccine manufacturer to commercialize needle-free delivery of the MMR vaccine through Stratis® 0.5mL needle-free injection system.
  • In January 2019, Vaxxas, an Australia-based company started working on boosting the performance of existing vaccines through a novel vaccine delivery technology called Nanopatch.
  • In January 2019, GeoVax and Enesi merged to develop a next-gen thermostable needle-free vaccine for various infectious diseases and emergent pathogens.
  • Major market players in vaccine delivery devices Becton Dickinson & Company, Inovio Pharmaceutical Inc., PharmaJet, Vaxxas, Gerresheimer AG, SCHOTT AG, Corium International, Inc., Vaxxas, Intravaac.

 

Target Audience:

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Global Vaccine Delivery Devices Market

1. Vaccine Delivery Devices Market – Methodology and Scope

1.1 Research methodology

1.2 Research Objective and Scope of the Report

2. Vaccine Delivery Devices Market – Industry Trends

3. Vaccine Delivery Devices Market Outlook

3.1 Market Snippet by Product Type

3.2 Market Snippet by Route of Administration

3.3 Market Snippet by Distribution Channel

3.4 Market Snippet by Region

3.5 DataM CLO Scenario

4. Vaccine Delivery Devices Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunity

4.4 Impact Analysis

5. Vaccine Delivery Devices Market – Industry Forces

5.1 Supply Chain Analysis

5.2 Pricing Analysis

5.3 Key Companies to Watch

5.4 Technology Developments

5.5 Epidemiology

5.6 PEST Analysis

5.7 PORTERS Five Forces

5.8 Regulations

6. Vaccine Delivery Devices Market Segmentation Analysis – By Product type

6.1 Jet Injectors

6.2 Syringes

6.3 Microneedles

6.4 Others

7. Vaccines Delivery Devices Market Segmentation Analysis – By Route of Administration

7.1 Subcutaneous vaccination

7.2 Intramuscular vaccination

7.3 Intra Dermal vaccination

7.4 Needle free delivery

8. Vaccines Delivery Devices Market Segmentation Analysis – By Distribution Channel

8.1 Online pharmacies

8.2 Retail pharmacies

8.3 Hospital pharmacies

8.4 Vaccination Centers

9. Vaccines Delivery Devices Market – Regional, Country-level Analysis

9.1 North America

9.1.1 U.S.

9.1.2 Canada

9.1.3 Mexico

9.2 Europe

9.2.1 Germany

9.2.2 U.K.

9.2.3 France

9.2.4 Italy

9.2.5 Spain

9.2.6 Rest of Europe

9.3 South America

9.3.1 Brazil

9.3.2 Argentina

9.3.3 Rest of South America

9.4 Asia Pacific

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 Australia

9.4.5 Rest of Asia Pacific

9.5 Middle East and Africa

10. Vaccine Delivery Devices Market – Competitive Analysis

10.1 Competitor Strategy Analysis

10.2 Comparative Product Portfolio Analysis

10.3 Market Positioning/Share Analysis

10.4 Mergers and Acquisitions Analysis

10.5 Competitive Scenario

11. Vaccine Delivery Devices Market – Company Profiles

11.1 3M*

11.2 Becton Dickinson & Company

11.3 Inovio Pharmaceutical Inc.

11.4 PharmaJet

11.5 Vaxxas

11.6 Gerresheimer AG

11.7 SCHOTT AG

11.8 Corium International, Inc.

11.9 Vaxxas

11.10 Intravaac

12. Vaccine Delivery Devices Market – Premium Insights

13. Vaccine Delivery Devices Market – DataM

13.1 Appendix

13.2 About Us and Services

13.3 Contact Us

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report